Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01769729 · ClinicalTrials.gov registry record · NA

Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial

A NA study, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01769729: Completed NA study, sponsored by Butler Hospital.

NCT01769729 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01769729, a NA study, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The overall aim of this program of research is to develop a collaborative psychotherapy for major depressive disorder (MDD) specifically for primary care patients with MDD and comorbid chronic low back pain (CLBP). The purpose of the proposed project is to establish the feasibility and acceptability of a research design for an eventual large-scale randomized clinical trial which would test the efficacy of PEPP in comparison to a control condition (depression care management). To achieve the investigators specific aims, the investigators will conduct a pilot randomized clinical trial (n = 30), with two treatment arms; PEPP (which includes procedures used in care management) or care management.

Primary Outcome

assessment of depression

Interventions

  • BEHAVIORAL Care management
  • BEHAVIORAL PEPP

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2012-12
Est. Completion 2014-02
Phase NA
Butler Hospital

103 total trials

What the finished NCT01769729 record still lists

NCT01769729 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Care management is the first listed.

NCT01769729 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01769729 about?

NCT01769729 is a clinical study titled "Program for Emotional and Physical Pain - Pilot Randomized Clinical Trial". The overall aim of this program of research is to develop a collaborative psychotherapy for major depressive disorder (MDD) specifically for primary care patients with MDD and comorbid chronic low back pain (CLBP). The purpose of the proposed project is to establish the feasibility and acceptabilit...

What is the current status of trial NCT01769729?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-12. Estimated completion is 2014-02.

What interventions are being tested in trial NCT01769729?

The interventions under investigation include: Care management (BEHAVIORAL), PEPP (BEHAVIORAL).

Who is sponsoring clinical trial NCT01769729?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01769729's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01769729, the US trial registry maintained by the National Library of Medicine. NCT01769729 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.